Cyren Announces $12 Million Private Placement Priced At-the-Market

Rhea-AI Summary

Cyren (Nasdaq:CYRN) has secured approximately $12 million in a private placement by issuing 3,129,075 ordinary shares at $3.835 each, along with warrants. The placement is priced 'at-the-market' and will close around February 14, 2022, subject to customary conditions. Proceeds will be utilized for working capital and corporate purposes. The company is also mandated to register the shares with the SEC within 15 days and aims for effectiveness within 80 days. The securities will not be publicly offered.

Positive

• Raised approximately $12 million in a private placement.
• Warrants have a term of five and a half years, providing potential for future capital.

Negative

• The securities are not registered under the Securities Act, limiting resale options.
• Additional regulatory risks associated with the SEC registration process.

MCLEAN, VA / ACCESSWIRE / February 10, 2022 / Cyren (Nasdaq:CYRN), today announced that it has entered into a securities purchase agreement with certain institutional and other accredited investors to raise approximately $12 million through the issuance of 3,129,075 of its ordinary shares (or ordinary share equivalents) and warrants to purchase up to 3,129,075 ordinary shares, at a purchase price of $3.835 per share (or ordinary share equivalent) and associated warrant, in a private placement priced "at-the-market" under Nasdaq Rules. The warrants will have a term of five and one-half years, be exercisable immediately following the issuance date and have an exercise price of $3.71 per ordinary share.

H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.

Cyren intends to use the net proceeds from the private placement for for working capital and general corporate purposes. The closing of the private placement is expected to occur on or about February 14, 2022, subject to satisfaction of customary closing conditions.

The offer and sale of the foregoing securities are being made in a transaction not involving a public offering and have not been registered under the Securities Act of 1933, as amended (the "Securities Act"), or applicable state securities laws. Accordingly, the securities may not be reoffered or resold in the United States except pursuant to an effective registration statement or an applicable exemption from the registration requirements of the Securities Act and such applicable state securities laws.

Under an agreement with the investors, Cyren is required to file an initial registration statement with the Securities and Exchange Commission (the "SEC") covering the resale of the ordinary shares to be issued to the investors (including the shares underlying the warrants) no later than 15 days after today and to use best efforts to have the registration statement declared effective as promptly as practical thereafter, and in any event no later than 80 days after today in the event of a "full review" by the Securities and Exchange Commission.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any sale of the securities in any state in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state.

About Cyren

More than 1.3 billion users around the world rely on Cyren's cloud security solutions to protect them against cyber attacks and data loss every day. Powered by GlobalView, Cyren's global security cloud that identifies emerging threats on a global basis in real-time, Cyren (Nasdaq:CYRN) delivers fast time-to-protection with threat detection services, threat intelligence and enterprise email security products for leading email providers, cybersecurity vendors, service providers and enterprises. Learn more at www.cyren.com.

Blog: https://www.cyren.com/blog
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Forward-Looking Statements

This press release contains forward-looking statements, which may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond Cyren's control, and cannot be predicted or quantified, and include, among others, statements regarding the consummation of the private placement and the intended use of proceeds, as well as various additional risks, many of which are now unknown and generally out of Cyren's control, and which are detailed from time to time in reports filed by Cyren with the SEC, including quarterly reports on Form 10-Q, reports on Form 8-K and annual reports on Form 10-K. Cyren does not undertake any duty to update any statements contained herein (including any forward-looking statements), except as required by law.

Company Contact:

Kenneth Tarpey, CFO
Cyren
+1.703.760.3320
Kenneth.tarpey@cyren.com

SOURCE: Cyren

View source version on accesswire.com:
https://www.accesswire.com/688247/Cyren-Announces-12-Million-Private-Placement-Priced-At-the-Market

FAQ

What is the purpose of Cyren's recent $12 million private placement?

Cyren intends to use the net proceeds for working capital and general corporate purposes.

When is the expected closing date for Cyren's private placement?

The closing is expected to occur on or about February 14, 2022.

What price per share was set for Cyren's private placement?

The shares were priced at $3.835 each in the private placement.

What are the terms of the warrants issued in Cyren's private placement?

The warrants have a term of five and a half years and an exercise price of $3.71 per ordinary share.

What obligations does Cyren have regarding SEC registration after the private placement?

Cyren must file a registration statement covering the resale of the ordinary shares within 15 days.